Related Experiment Video
Updated: Aug 9, 2025
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
Hamza El Hadi1, Anne Freund1, Steffen Desch1
1Department of Internal Medicine/Cardiology, Heart Center Leipzig, University of Leipzig, Strümpellstr. 39, 04289 Leipzig, Germany.
Insights
Cardiomyopathies are heart muscle diseases leading to heart failure and sudden death. Recent advances improve understanding and management, focusing on disease mechanisms and early prevention strategies.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathies encompass diverse heart muscle disorders causing arrhythmias, heart failure, and significant mortality.
- These conditions are a primary indication for heart transplantation globally.
- Recent progress has enhanced understanding of molecular underpinnings, diagnostics, and management.
Purpose of the Study:
- To review current knowledge on hypertrophic, dilated, and arrhythmogenic cardiomyopathies.
- To emphasize pathophysiology, clinical presentation, and diagnostic strategies.
- To highlight novel therapeutic approaches and knowledge gaps.
Main Methods:
- Comprehensive literature review of recent advancements in cardiomyopathy research.
- Synthesis of information on molecular basis, clinical features, and diagnostic modalities.
- Analysis of ongoing studies and identification of future research directions.
Main Results:
- Significant progress in understanding disease mechanisms and refining diagnostic tools.
- Shift in treatment focus from symptom management to targeting underlying disease drivers.
- Ongoing research aims to improve risk stratification for sudden cardiac death prevention.
Conclusions:
- Cardiomyopathies require a multi-faceted approach, integrating molecular insights with clinical practice.
- Further research is crucial for precise patient selection for interventions like defibrillator implantation.
- Continued investigation into novel management strategies is essential for improving patient outcomes.
Abstract:
Cardiomyopathies are a heterogeneous group of structural, mechanical, and electrical heart muscle disorders which often correlate with life-threatening arrhythmias and progressive heart failure accounting for significant cardiovascular morbidity and mortality. Currently, cardiomyopathies still represent a leading reason for heart transplantation worldwide. The last years have brought remarkable advances in the field of cardiomyopathies especially in terms of understanding the molecular basis as well as the diagnostic evaluation and management. Although most cardiomyopathy treatments had long focused on symptom management, much of the current research efforts aim to identify and act on the disease-driving mechanisms. Regarding risk assessment and primary prevention of sudden cardiac death, additional data are still pending in order to pave the way for a more refined and early patient selection for defibrillator implantation. This review summarizes the current knowledge of hypertrophic, dilated and arrhythmogenic cardiomyopathy with a particular emphasis on their pathophysiology, clinical features, and diagnostic approach. Furthermore, the relevant ongoing studies investigating novel management approaches and main gaps in knowledge are highlighted.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:25Cardiomyopathy I: Introduction and Classification
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:29Cardiomyopathy V: Interprofessional Care
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
01:29Heart Failure II: Pathophysiology